Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
11/06

DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ rose 2.40% to $7.69 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.65% to 23,499.80 and the Dow Jones Industrial Average rising 0.48% to 47,311.00.

The stock's rise snapped a three-day losing streak.

Novavax Inc. closed 33.42% short of its 52-week high of $11.55, which the company reached on January 7th.

The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.46% to $186.00, Pfizer Inc. $(PFE)$ rose 1.28% to $24.61, and Merck & Co. Inc. $(MRK)$ rose 0.63% to $84.39.

Trading volume (5.0 M) eclipsed its 50-day average volume of 4.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 5, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 05, 2025 17:31 ET (22:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10